Brentuximab Vedotin in Advanced Hodgkin's Lymphoma

被引：0
|
作者：
Ansell, Stephen M. [1 ]
Radford, John [2 ]
Straus, David J. [3 ]
机构：
[1] Mayo Clin, Rochester, MN 55902 USA
[2] Univ Manchester, Manchester, England
[3] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2022年 / 387卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1527 / 1528
页数：2
相关论文
共 50 条
  • [1] Brentuximab vedotin for advanced Hodgkin's lymphoma
    Fanale, Michelle A.
    LANCET ONCOLOGY, 2017, 18 (12): : 1566 - 1568
  • [2] Brentuximab vedotin in Hodgkin's lymphoma
    Pro, Barbara
    Perini, Guilherme Fleury
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (10) : 1415 - 1421
  • [3] Brentuximab vedotin and its use in the treatment of advanced Hodgkin's lymphoma
    Nikolaenko, Liana
    Nademanee, Auayporn
    FUTURE ONCOLOGY, 2020, 16 (29) : 2273 - 2282
  • [4] Brentuximab Vedotin in Children with Hodgkin's Lymphoma
    Kazantsev, I.
    Kozlov, A.
    Iukhta, T.
    Gevorgian, A.
    Tolkunova, P.
    Tsvetkova, L.
    Morozova, E.
    Lepik, K.
    Kulagin, A.
    Mikhailova, N.
    Zubarovskaya, L.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S202 - S202
  • [5] Brentuximab vedotin for the treatment of Hodgkin's lymphoma
    Anh Pham
    Chen, Robert
    EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (04) : 403 - 412
  • [6] Brentuximab vedotin for relapsed or refractory Hodgkin's lymphoma
    Chen, Runzhe
    Chen, Baoan
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 1729 - 1733
  • [7] BRENTUXIMAB VEDOTIN IS EFFECTIVE IN HODGKIN LYMPHOMA
    不详
    CANCER DISCOVERY, 2012, 2 (05) : 385 - 385
  • [8] Significance of Brentuximab Vedotin in the Treatment of Hodgkin's Lymphoma
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (04) : 230 - 231
  • [9] Brentuximab vedotin and transplantation in Hodgkin Lymphoma
    Castagna, Luca
    Sarina, Barbara
    Bramanti, Stefania
    Calabretta, Eleonora
    Mariotti, Jacopo
    Morabito, Lucio
    DRUGS AND CELL THERAPIES IN HEMATOLOGY, 2015, 3 (04): : 218 - 225
  • [10] Brentuximab vedotin for the treatment of Hodgkin's and non-Hodgkin's lymphoma
    Reagan, Patrick M.
    Friedberg, Jonathan W.
    EXPERT OPINION ON ORPHAN DRUGS, 2015, 3 (05): : 609 - 618
12345